SCHEMBL6696772

SCHEMBL6696772

C=CCc1cccc(C2OC=CO2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
CYP3A4 P08684 4/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.41
XDH P47989 1/20 0.38
MAPT P10636 3/20 0.38
CYP1A2 P05177 1/20 0.38
GABRA1 P14867 3/20 0.37
GABRB2 P47870 3/20 0.37
PPARG P37231 2/20 0.37
PPARD Q03181 2/20 0.37
MEN1 O00255 2/20 0.37
GAA P10253 2/20 0.37
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH2 P05091 1/20 0.37
AKR1B1 P15121 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL50479 0.77 TSHR (0.38) TSHR
SCHEMBL5311499 0.77 CHRNB4 (0.43) TSHR
SCHEMBL189832 0.77 TRPA1 (0.38) ALDH1A1TSHR
SCHEMBL28154654 0.75 ALDH1A1 (0.54) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL1325860 0.74 XDH (0.54) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2655669 0.74 TDP1 (0.42)
SCHEMBL6934088 0.74 DRD2 (0.44) CNR1CNR2GRIN2DGRIN3BGRIN1
SCHEMBL4140760 0.73 TP53 (0.44) ALDH1A1PTGS2TP53TSHR
Ethylene SCHEMBL28753621 0.72 XDH (0.52) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19
Water SCHEMBL28099990 0.72 XDH (0.52) ALDH1A1CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040181094-A1 Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE 2004-09-16 US disclosed
EP-1140894-B1 PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS ENDURA SPA (IT) 2003-12-17 EP disclosed
EP-1048664-B1 Process for the synthesis of 5-alkybenzodioxoles ENDURA SPA (IT) 2002-11-13 EP disclosed
US-6342613-B1 REACTING PYROCATECHOL WITH DIHALO- OR DI-ALKOXYALKANE, ACYLATING BENZO(1,3)DIOXOLE DERIVATIVE FORMED IN PRESENCE OF CATALYST, REDUCING TO 5-(ALPHA-HYDROXYALKYL)BENZO(1,3)DIOXOLE ENDURA S.P.A. (IT) 2002-01-29 US disclosed
EP-1140894-A1 PROCESS FOR THE SYNTHESIS OF 5-(ALPHA -HYDROXYALKYL) BENZO 1, 3]DIOXOLS ENDURA S.p.A. (IT) 2001-10-10 EP disclosed
US-6252092-B1 CATALYTIC HYDROGENATION OF 4-ACYLPHENOL; ACETYLATION; REACTING WITH A LEWIS ACID; THEN HYDROGEN PEROXIDE; CYCLIZATION ENDURA S.P.A. (IT) 2001-06-26 US disclosed
EP-1048664-A2 Process for the synthesis of 5-allybenzodioxoles ENDURA S.p.A. (IT) 2000-11-02 EP disclosed
WO-2000040575-A1 PROCESS FOR THE SYNTHESIS OF 5-(α -HYDROXYALKYL) BENZO[1, 3]DIOXOLS ENDURA S.P.A. (IT) 2000-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040181094-A1 Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants POLR1G, PYM1, APEX1 ALDH1A1 3099/4885CYP3A4 269/4885CYP2D6 1045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.